Peter Goldschmidt has 40 years of experience in government and for-profit organizations within health policy, quality, regulatory, and reimbursement. Dr. Goldschmidt previously served as a Director of the Health Services Research and Development Service, U.S. Department of Veterans Affairs (VA), Washington, D.C.

Monica Welling is a decisive biopharma C-level executive with over 25 years experience and proven success developing and implementing domestic and global product development and commercialization strategies in start-up to mid-sized biopharma companies. She has broad experience in portfolio management, new product planning, strategic planning and commercial development of marketed products in all phases of development, along with her experience in pre-launch and launching of products, medical devices, and new product initiatives both domestically and globally.

Dr. Michael Dacey is a board certified dermatologist and 16 year veteran of the Palo Alto Medical Foundation (a division of Sutter Health). He is a graduate of the University of Notre Dame and did his medical training at the University of Louisville. The sole focus of his practice is management and advancements in the treatment of skin cancer, having performed over 15,000 melanoma and non-melanoma (basal cell, squamous cell, other) skin cancer surgeries. Dr. Dacey has served as an advisor to multiple medical startup companies which included product development and capital fundraising.

Dr. Leachman is a physician-scientist who chairs the Department of Dermatology at Oregon Health & Science University (OHSU) and is the director of the Melanoma Research Program at the OHSU Knight Cancer Institute, an NCI-designated Comprehensive Cancer Center. Dr. Leachman earned an M.D., Ph.D. at the University of Texas Southwestern Medical School, 1993 and her B.A. at the University of Texas at Austin Plan II, 1985. Her residency was at Yale-New Haven Hospital (dermatology) in New Haven, CT; she completed a Fellowship in cutaneous oncology at Yale University School of Medicine, and is certified by the American Board of Dermatology.

Dr. Kulkarni is Vice Chair for Research and Associate Professor in Dept. of Dermatology, Biomedical Engineering, and CEDAR/Knight Cancer Institute at the OHSU. He leads a research lab which focuses on translational applications of single-cell heterogeneity in cancer, including melanoma, and has been one of the leaders in tissue processing and analysis using the PACT and PARS CLARITY methods that he helped to develop, particularly for improving understanding of 3D skin and melanoma tumor architecture.

Dr. Wang is a practicing dermatologist at Golden State Dermatology with current research focus on applications of deep learning to dermatology.

Dr. Christos is an Associate Research Professor of Population Health Sciences and Director of the Biostatistics, Epidemiology and Research Design Core of the WCMC Clinical and Translational Science Center at Weill Cornell Medicine. He specializes in identification of research questions, construction of hypotheses, design of investigative studies and data collection strategies, statistical analyses of data and interpretation of research findings.